| Literature DB >> 16013042 |
Yong Keun Kim1, Hyun Ju Kim, Chae Hwa Kwon, Jae Ho Kim, Jae Suk Woo, Jin Sup Jung, Jong Min Kim.
Abstract
Cisplatin induces apoptosis in a variety of cell types. However, the signaling pathway of cisplatin-induced apoptosis in renal epithelial cells is poorly understood. The present study was undertaken to determine the role of the extracellular signal-regulated kinase (ERK) in cisplatin-induced apoptosis of renal epithelial cells using opossum kidney cells. Cisplatin at 50 microM induced apoptosis in a time-dependent manner. Cisplatin treatment caused sustained activation of ERK1/2, which was prevented by PD98059 and U0126, inhibitors of ERK1/2 upstream kinase MEK1/2. Transient transfection of cells with constitutive active MEK1 increased the cisplatin-induced apoptosis, whereas that with a dominant-negative mutant of MEK1 decreased it. Cisplatin induced an increase in Bax expression, mitochondrial membrane depolarization, mitochondrial cytochrome c release and caspase-3 activation, and these changes were prevented by the MEK inhibitor. These results suggested that (1) the ERK1/2 activation is required for the cisplatin-induced apoptosis of renal epithelial cells; and (2) ERK1/2 mediates the mitochondria-dependent apoptotic signaling by acting upstream of Bax expression. 2005 John Wiley & Sons, Ltd.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16013042 DOI: 10.1002/jat.1081
Source DB: PubMed Journal: J Appl Toxicol ISSN: 0260-437X Impact factor: 3.446